Readystate Asset Management LP Invests $1.43 Million in CVS Health Corporation $CVS

Readystate Asset Management LP acquired a new stake in CVS Health Corporation (NYSE:CVS) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 18,966 shares of the pharmacy operator’s stock, valued at approximately $1,430,000.

A number of other large investors also recently bought and sold shares of CVS. Avion Wealth lifted its stake in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC bought a new position in shares of CVS Health in the 3rd quarter worth about $29,000. Front Row Advisors LLC grew its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in CVS Health during the second quarter worth about $36,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS stock opened at $77.81 on Thursday. The company has a 50-day simple moving average of $78.65 and a 200 day simple moving average of $76.57. The company has a market capitalization of $98.99 billion, a P/E ratio of 56.38, a PEG ratio of 0.82 and a beta of 0.50. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CVS. Jefferies Financial Group boosted their price objective on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Piper Sandler reiterated an “overweight” rating and issued a $101.00 target price (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Evercore increased their price objective on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, TD Cowen upped their target price on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.